AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Silo Pharma, Inc. Director's Dealing 2014

Aug 1, 2014

35304_dirs_2014-08-01_ebd0bf10-b7c3-4b13-a500-cf8a6abd9db7.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Point Capital, Inc. (PTCI)
CIK: 0001514183
Period of Report: 2014-07-30

Reporting Person: SCHILLER LEONARD M (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	37500	Direct